STILBENE DERIVATIVES AS PSTAT3/IL-6 INHIBITORS Patent uri icon

abstract

  • Described are novel compounds of the formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These novel compounds can inhibit pSTAT3/IL-6 and are useful as a therapeutic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, autoimmune diseases, skin diseases, infections, inflammation, etc.

author list (cited authors)

  • RAJAGOPAL SRIDHARAN, .., SELVAKUMAR THANGAPAZHAM, .., BHARATHIMOHAN KUPPUSAMY, .., KACHHADIA VIRENDRA, .., RAJAGOPAL SRIRAM, .., PRAVEEN RAJENDRAN, .., & BALAJI RAMACHANDRAN.

publication date

  • November 2008